- Funding roundup: Megarounds for Strand and Minghui, plus SNIPR snags €35M FirstWord Pharma
- MIT Spinout Strand Therapeutics Raises $153 Million To Make Cancerous Tumors Light Up Forbes
- Big Pharmas back Strand’s $153M series B to advance mRNA drugs Fierce Biotech
- Strand Therapeutics Raises $153 Million Series B Financing to Further Advance Programmable mRNA Therapeutic Pipeline Business Wire
- LG deepens bio push with US anticancer biotech The Korea Herald
The wire
More investor news
Sequoia shuts London office as VC firm refocuses on Silicon Valley – Financial Times
Japan Exchange’s venture arm backs startup platform Smartround with $1.89M – Dealroom
Europe’s Defense Tech Boom: Investment, Gaps – The Recursive
e2vc targets $150M growth fund, pushing assets to $600M – Dealroom
Ex-Hummingbird investor plots new VC firm, sources say – Sifted
Sequoia to close London office, cut Europe team – Sifted